Studies have shown that quercitrin significantly inhibits the growth and proliferation of tumor cells through MAPK/ERK and AKT/mTOR (81, 82), which corresponds to the pathophysiology of ADPKD. The gene discussed is MTOR; the disease is autosomal dominant polycystic kidney disease.